BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 6515423)

  • 1. Clinical implications of molecular markers in hemostasis and thrombosis.
    Bick RL
    Semin Thromb Hemost; 1984 Oct; 10(4):290-3. PubMed ID: 6515423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical hemostasis practice: the major impact of laboratory automation.
    Bick RL
    Semin Thromb Hemost; 1983 Jul; 9(3):139-71. PubMed ID: 6412362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A guide for diagnosis of patients with arterial and venous thrombosis.
    Quinn C; Hill J; Hassouna H
    Clin Lab Sci; 2000; 13(4):229-38. PubMed ID: 11586510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis and of the Japanese Ministry of Health and Welfare for overt DIC.
    Wada H; Gabazza EC; Asakura H; Koike K; Okamoto K; Maruyama I; Shiku H; Nobori T
    Am J Hematol; 2003 Sep; 74(1):17-22. PubMed ID: 12949885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disorders of the hemostatic system in patients with disseminated stomach cancer].
    Tiutrin II; Karpov AB; Udut VV; Tsisik RM; Solokhina EA
    Vopr Onkol; 1989; 35(4):460-5. PubMed ID: 2728389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of fibrinolysis laboratory tests: a review.
    Prisco D; Conti AA; Giurlani L; Falciani M
    Ann Ital Med Int; 1998; 13(2):81-7. PubMed ID: 9734140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory diagnosis of hemorrhagic and thrombotic disorders.
    Kottke-Marchant K
    Hematol Oncol Clin North Am; 1994 Aug; 8(4):809-53. PubMed ID: 7961292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular markers for the blood coagulation and fibrinolysis].
    Okajima K
    Rinsho Byori; 2001 Mar; Suppl 115():74-90. PubMed ID: 11391940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravascular coagulation. 1. Differential diagnosis and conditioning mechanisms.
    Grainick HR
    Postgrad Med; 1977 Nov; 62(5):68-75, 87. PubMed ID: 917953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation studies: prothrombin time, partial thromboplastin time, bleeding time.
    Angelos MG; Hamilton GC
    Emerg Med Clin North Am; 1986 Feb; 4(1):95-113. PubMed ID: 3512249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The thrombelastographic diagnosis of hemostatic defects.
    Franz RC; Coetzee WJ
    Surg Annu; 1981; 13():75-107. PubMed ID: 7025290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypercoagulemic disorders of hemostasis and disseminated intravascular coagulation syndromes (clinical, diagnostic, treatment and prophylactic problems)].
    Levitskaia SV
    Pediatriia; 1984 Jun; (6):69-73. PubMed ID: 6473003
    [No Abstract]   [Full Text] [Related]  

  • 13. [Disorders of blood coagulation in the intensive care unit: what is important for diagnosis and therapy?].
    Seitz R; Egbring R
    Klin Wochenschr; 1991; 69 Suppl 26():143-9. PubMed ID: 1813711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated intravascular coagulation: objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic response.
    Bick RL
    Semin Thromb Hemost; 1996; 22(1):69-88. PubMed ID: 8711492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
    Bokarev IN; Butorov VN; Loginov LE
    Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
    [No Abstract]   [Full Text] [Related]  

  • 16. Overview of Hemostasis and Thrombosis and Contribution of Laboratory Testing to Diagnosis and Management of Hemostasis and Thrombosis Disorders.
    Bonar RA; Lippi G; Favaloro EJ
    Methods Mol Biol; 2017; 1646():3-27. PubMed ID: 28804815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated intravascular coagulation. Objective laboratory diagnostic criteria and guidelines for management.
    Bick RL
    Clin Lab Med; 1994 Dec; 14(4):729-68. PubMed ID: 7874869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation abnormalities in malignancy: a review.
    Bick RL
    Semin Thromb Hemost; 1992; 18(4):353-72. PubMed ID: 1470924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.